Head to Head Comparison: ReWalk Robotics (LFWD) versus Its Peers

ReWalk Robotics (NASDAQ:LFWD) is one of 44 public companies in the “Surgical appliances & supplies” industry, but how does it compare to its peers? We will compare ReWalk Robotics to related companies based on the strength of its risk, analyst recommendations, profitability, earnings, valuation, institutional ownership and dividends.

Profitability

This table compares ReWalk Robotics and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ReWalk Robotics	-159.76%	-28.19%	-23.29%
ReWalk Robotics Competitors	-65.16%	-71.96%	-13.50%

Institutional and Insider Ownership

26.8% of ReWalk Robotics shares are held by institutional investors. Comparatively, 47.7% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 2.1% of ReWalk Robotics shares are held by insiders. Comparatively, 8.7% of shares of all “Surgical appliances & supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

ReWalk Robotics has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, ReWalk Robotics’ peers have a beta of 0.86, indicating that their average stock price is 14% less volatile than the S&P 500.

Valuation and Earnings

This table compares ReWalk Robotics and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
ReWalk Robotics	$13.85 million	-$22.13 million	-1.82
ReWalk Robotics Competitors	$1.58 billion	$173.59 million	32.38

ReWalk Robotics’ peers have higher revenue and earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings for ReWalk Robotics and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ReWalk Robotics	0	0	1	0	3.00
ReWalk Robotics Competitors	340	1169	2240	98	2.54

ReWalk Robotics currently has a consensus target price of $21.00, indicating a potential upside of 301.53%. As a group, “Surgical appliances & supplies” companies have a potential upside of 2.43%. Given ReWalk Robotics’ stronger consensus rating and higher probable upside, research analysts clearly believe ReWalk Robotics is more favorable than its peers.

Summary

ReWalk Robotics peers beat ReWalk Robotics on 8 of the 13 factors compared.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.